Details of the Drug Combinations

General Information of This Drug (ID: DMNER5S)

Drug Name
Bleomycin   DMNER5S
Synonyms
BLM; Blenoxane; Bleo; Bleocin; Bleogin; Bleomicin; Bleomicina; Bleomycine; Bleomycins; Bleomycinum; Bleomycin sulfate; Bleomycin a2; Pingyangmyvin A2; Zhengguangmycin A2; Zhengguangmycin A2 [Chinese]; Blenoxane (TN); Bleomicina [INN-Spanish]; Bleomycin A(2); Bleomycin A2 & Bleomycin B2; Bleomycin B(2); Bleomycine [INN-French]; Bleomycinum [INN-Latin]; NDC 0015-3010; N(1)-[3-(dimethylsulfonio)propyl]bleomycinamide; N1-(3-(Dimethylsulfonio)propyl)bleomycinamide
Indication
Disease Entry ICD 11 Status REF
Cervical cancer 2C77.0 Approved [1]
Head and neck cancer 2D42 Approved [1]
Hodgkin lymphoma 2B30 Approved [2]
Penile cancer N.A. Approved [1]
Testicular germ cell tumor N.A. Approved [1]
Classic Hodgkin lymphoma N.A. Investigative [1]
Follicular lymphoma 2A80 Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1076 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
10-hydroxycamptothecin + Bleomycin DCGVT54 10-hydroxycamptothecin Anaplastic large cell lymphoma (Cell Line: SR) [3]
10-hydroxycamptothecin + Bleomycin DCDD3MS 10-hydroxycamptothecin Astrocytoma (Cell Line: U251) [3]
ABIRATERONE + Bleomycin DCK4ONP ABIRATERONE Astrocytoma (Cell Line: SNB-19) [3]
ABIRATERONE + Bleomycin DC3DGW8 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ABIRATERONE + Bleomycin DCJKQE3 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
ABIRATERONE + Bleomycin DCIUTHU ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ABIRATERONE + Bleomycin DCP981X ABIRATERONE Glioblastoma (Cell Line: SNB-75) [3]
ABIRATERONE + Bleomycin DCCPTW3 ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Bleomycin DCFM2ML ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ABIRATERONE + Bleomycin DC6VV7D ABIRATERONE Carcinoma (Cell Line: MCF7) [4]
ABIRATERONE + Bleomycin DCC1I2V ABIRATERONE Colon carcinoma (Cell Line: KM12) [4]
ABIRATERONE + Bleomycin DC3CFQF ABIRATERONE Adenocarcinoma (Cell Line: A549) [5]
ABIRATERONE + Bleomycin DCAF16T ABIRATERONE Adenocarcinoma (Cell Line: SW-620) [5]
ABIRATERONE + Bleomycin DCJYGVE ABIRATERONE Adenocarcinoma (Cell Line: HT29) [5]
ABIRATERONE + Bleomycin DC63V5E ABIRATERONE Adenocarcinoma (Cell Line: HCT-15) [5]
ABIRATERONE + Bleomycin DCJG2Q8 ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
ABIRATERONE + Bleomycin DCXATRV ABIRATERONE Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
ABIRATERONE + Bleomycin DC8PP1Y ABIRATERONE Lung adenocarcinoma (Cell Line: HOP-62) [5]
ABIRATERONE + Bleomycin DC53PYK ABIRATERONE Lung adenocarcinoma (Cell Line: EKVX) [5]
ABIRATERONE + Bleomycin DCROH9S ABIRATERONE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
ABIRATERONE + Bleomycin DCJW50F ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [5]
ABIRATERONE + Bleomycin DC0V6B6 ABIRATERONE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Amonafide + Bleomycin DCNIET4 Amonafide Adenocarcinoma (Cell Line: DU-145) [3]
Amonafide + Bleomycin DCUHSSF Amonafide Adenocarcinoma (Cell Line: A549) [3]
Amonafide + Bleomycin DCPJVG8 Amonafide Adenocarcinoma (Cell Line: HT29) [3]
Amonafide + Bleomycin DCQVOPE Amonafide Adenocarcinoma (Cell Line: HCT-15) [3]
Amonafide + Bleomycin DCPCDL1 Amonafide Adenocarcinoma (Cell Line: SW-620) [3]
Amonafide + Bleomycin DC1BESM Amonafide Adenocarcinoma (Cell Line: HCT116) [3]
Amonafide + Bleomycin DCG2878 Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Amonafide + Bleomycin DC43HFW Amonafide Astrocytoma (Cell Line: U251) [3]
Amonafide + Bleomycin DCWGFT2 Amonafide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Amonafide + Bleomycin DCGLR48 Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Amonafide + Bleomycin DCHD8UH Amonafide Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Amonafide + Bleomycin DCJ1UC5 Amonafide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Amonafide + Bleomycin DCDTXIP Amonafide Glioma (Cell Line: SF-268) [3]
Amonafide + Bleomycin DCU0QZB Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Amonafide + Bleomycin DC1N2TF Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Amonafide + Bleomycin DC1YJ0A Amonafide Melanoma (Cell Line: SK-MEL-2) [3]
Amonafide + Bleomycin DCQR9XV Amonafide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Amonafide + Bleomycin DCRZUA9 Amonafide Carcinoma (Cell Line: MCF7) [4]
Amonafide + Bleomycin DCSXEP4 Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Amonafide + Bleomycin DCJ6STI Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Amonafide + Bleomycin DCLJWK3 Amonafide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Anastrozole + Bleomycin DCL07Y4 Anastrozole Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Bleomycin DCJPK9M Anastrozole Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Bleomycin DCBMWFH Anastrozole Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Bleomycin DCP3S2A Anastrozole Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Bleomycin DC8Y7M4 Anastrozole Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Bleomycin DCA229E Anastrozole Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Bleomycin DCBKWEC Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Bleomycin DC0E2Y1 Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Bleomycin DCLKWT5 Anastrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Bleomycin DCGDFI6 Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Bleomycin DCGH2PU Anastrozole Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Bleomycin DC36ZL2 Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Bleomycin DC9KFJA Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Bleomycin DCDYXVD Anastrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Bleomycin DCLI8G8 Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Bleomycin DCMR319 Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Bleomycin DCX0LVX Anastrozole Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Bleomycin DCJBTUD Anastrozole Glioma (Cell Line: SF-268) [3]
Anastrozole + Bleomycin DC47PXH Anastrozole Glioma (Cell Line: SF-539) [3]
Anastrozole + Bleomycin DCZ98V0 Anastrozole Glioma (Cell Line: SF-295) [3]
Anastrozole + Bleomycin DCYZ7UV Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Bleomycin DC98VLY Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Bleomycin DC6N2AK Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Bleomycin DC1DN9R Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Bleomycin DC68RV7 Anastrozole Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Bleomycin DCNP4GV Anastrozole Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Bleomycin DCACRO0 Anastrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Bleomycin DCKN7LD Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Bleomycin DCLRV8D Anastrozole Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Bleomycin DCIB7EA Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Bleomycin DCENW07 Anastrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Bleomycin DCQYOCE Anastrozole Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Bleomycin DC2M1CK Anastrozole Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Bleomycin DC4ZJ08 Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Bleomycin DCWQ6AD Anastrozole Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Bleomycin DC1WGMM Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Bleomycin DCY21HT Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Bleomycin DCUPAPJ Anastrozole Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Bleomycin DCTJ00V Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Bleomycin DCULZVW Anastrozole Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Bleomycin DCKWBA8 Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Anastrozole + Bleomycin DC63HP7 Anastrozole Carcinoma (Cell Line: RXF 393) [4]
Anastrozole + Bleomycin DCGVFDE Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [4]
Anastrozole + Bleomycin DC8RNNV Anastrozole Colon carcinoma (Cell Line: KM12) [4]
Anastrozole + Bleomycin DCVRVC5 Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Arfolitixorin + Bleomycin DCIIVWO Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Arfolitixorin + Bleomycin DCOZBS4 Arfolitixorin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Arfolitixorin + Bleomycin DC3S00T Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Arfolitixorin + Bleomycin DC0RDVT Arfolitixorin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Arfolitixorin + Bleomycin DCXMYSW Arfolitixorin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Arfolitixorin + Bleomycin DC0PW1H Arfolitixorin Adenocarcinoma (Cell Line: SW-620) [5]
Arfolitixorin + Bleomycin DCEJI56 Arfolitixorin Melanoma (Cell Line: SK-MEL-2) [5]
Azacitidine + Bleomycin DC4PN3H Azacitidine Adenocarcinoma (Cell Line: HCT116) [3]
Azacitidine + Bleomycin DCE06QG Azacitidine Chronic myelogenous leukemia (Cell Line: K-562) [3]
BIO-300 + Bleomycin DCO50A4 BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
BIO-300 + Bleomycin DCMV8BE BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
BIO-300 + Bleomycin DCRJHOG BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [3]
BIO-300 + Bleomycin DC304HQ BIO-300 Astrocytoma (Cell Line: U251) [3]
BIO-300 + Bleomycin DC8ZIGX BIO-300 Astrocytoma (Cell Line: SNB-19) [3]
BIO-300 + Bleomycin DCZ6DFM BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
BIO-300 + Bleomycin DC2YPZ8 BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [3]
BIO-300 + Bleomycin DCNHC16 BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
BIO-300 + Bleomycin DC6NHMT BIO-300 Clear cell renal cell carcinoma (Cell Line: A498) [3]
BIO-300 + Bleomycin DC354OV BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
BIO-300 + Bleomycin DCMFEJO BIO-300 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
BIO-300 + Bleomycin DCQ8K11 BIO-300 Glioblastoma (Cell Line: SNB-75) [3]
BIO-300 + Bleomycin DCCEQYH BIO-300 Glioma (Cell Line: SF-268) [3]
BIO-300 + Bleomycin DCGKGRE BIO-300 Glioma (Cell Line: SF-539) [3]
BIO-300 + Bleomycin DCWDKRP BIO-300 Glioma (Cell Line: SF-295) [3]
BIO-300 + Bleomycin DCYSK81 BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
BIO-300 + Bleomycin DCUUJ47 BIO-300 Renal cell carcinoma (Cell Line: SN12C) [3]
BIO-300 + Bleomycin DCEC6CR BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
BIO-300 + Bleomycin DC2VSQR BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [4]
BIO-300 + Bleomycin DC3D7EE BIO-300 Colon carcinoma (Cell Line: KM12) [4]
BIO-300 + Bleomycin DC01CJE BIO-300 Invasive ductal carcinoma (Cell Line: BT-549) [4]
BIO-300 + Bleomycin DCXWR0K BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
BIO-300 + Bleomycin DC2JRFI BIO-300 Adenocarcinoma (Cell Line: DU-145) [5]
BIO-300 + Bleomycin DC85IU0 BIO-300 Adenocarcinoma (Cell Line: OVCAR3) [5]
BIO-300 + Bleomycin DC9OOHQ BIO-300 Adenocarcinoma (Cell Line: A549) [5]
BIO-300 + Bleomycin DCSDYQA BIO-300 Adenocarcinoma (Cell Line: HCT116) [5]
BIO-300 + Bleomycin DCSFYUI BIO-300 Adenocarcinoma (Cell Line: SW-620) [5]
BIO-300 + Bleomycin DC13147 BIO-300 Adenocarcinoma (Cell Line: HCT-15) [5]
BIO-300 + Bleomycin DCTO54C BIO-300 Adenocarcinoma (Cell Line: HCC-2998) [5]
BIO-300 + Bleomycin DC0OCST BIO-300 Amelanotic melanoma (Cell Line: M14) [5]
BIO-300 + Bleomycin DCWPQXH BIO-300 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
BIO-300 + Bleomycin DC6NCGE BIO-300 Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
BIO-300 + Bleomycin DCRZPG9 BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
BIO-300 + Bleomycin DC2JP98 BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
BIO-300 + Bleomycin DCS8V89 BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
BIO-300 + Bleomycin DCMXPAB BIO-300 Lung adenocarcinoma (Cell Line: HOP-62) [5]
BIO-300 + Bleomycin DCZSDMS BIO-300 Lung adenocarcinoma (Cell Line: EKVX) [5]
BIO-300 + Bleomycin DC4VNHN BIO-300 Malignant melanoma (Cell Line: UACC62) [5]
BIO-300 + Bleomycin DCJNYPK BIO-300 Malignant melanoma (Cell Line: LOX IMVI) [5]
BIO-300 + Bleomycin DC01PE4 BIO-300 Melanoma (Cell Line: UACC-257) [5]
BIO-300 + Bleomycin DCWAAN5 BIO-300 Melanoma (Cell Line: SK-MEL-2) [5]
BIO-300 + Bleomycin DCFOYZN BIO-300 Melanoma (Cell Line: MALME-3M) [5]
BIO-300 + Bleomycin DC43L41 BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
BIO-300 + Bleomycin DCPTKQN BIO-300 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Mechlorethamine DCGDQWF Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Mechlorethamine DCHXEAM Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Mechlorethamine DCE3E1F Mechlorethamine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Pentostatin DCX5DQI Pentostatin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Pentostatin DCA9NVF Pentostatin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Ixabepilone DCR4FH3 Ixabepilone Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Ixabepilone DCI0KMB Ixabepilone Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Ixabepilone DCE9HY5 Ixabepilone Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Ixabepilone DCTUSD6 Ixabepilone Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Dactinomycin DCXYOZ9 Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Dactinomycin DC7ZZAT Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Dactinomycin DCH479N Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Dactinomycin DC175PE Dactinomycin Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Dactinomycin DCA3W4I Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Dactinomycin DCQN99X Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Dactinomycin DCN9NG6 Dactinomycin Glioma (Cell Line: SF-539) [3]
Bleomycin + Dactinomycin DCZZOSY Dactinomycin Glioma (Cell Line: SF-268) [3]
Bleomycin + Dactinomycin DCFGECB Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Lapatinib DCMAUFX Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Lapatinib DC956JE Lapatinib Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + PMID28460551-Compound-2 DC6MTJH PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + PMID28460551-Compound-2 DCNHQWL PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Crizotinib DC08EVO Crizotinib Glioma (Cell Line: SF-295) [3]
Bleomycin + LIAROZOLE DCJSLJ1 LIAROZOLE Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Methotrexate DCRX9C9 Methotrexate Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Methotrexate DC5IYQK Methotrexate Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Bleomycin + Isoniazid DCGINLN Isoniazid Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Arsenic trioxide DC4BJG1 Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Arsenic trioxide DCM5E68 Arsenic trioxide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Arsenic trioxide DCP9OFD Arsenic trioxide Glioblastoma (Cell Line: SNB-75) [3]
Bleomycin + Plicamycin DCRMF3U Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Plicamycin DCO9KSY Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Plicamycin DC681BC Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Plicamycin DC1ZE0M Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Plicamycin DCMVX8Y Plicamycin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Bleomycin + Plicamycin DCK9A4K Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Bleomycin + Plicamycin DC8HR79 Plicamycin Glioma (Cell Line: SF-539) [3]
Bleomycin + Plicamycin DCZH4IP Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Nilotinib DCN7V0R Nilotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Nilotinib DCQRJG7 Nilotinib Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Thioguanine DCG9PGF Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Thioguanine DCMMBL5 Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Thioguanine DCZPNDG Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Thioguanine DCEYOBA Thioguanine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Thioguanine DC93VD1 Thioguanine Glioblastoma (Cell Line: SNB-75) [3]
Bleomycin + Thioguanine DCX3ZNP Thioguanine Glioma (Cell Line: SF-268) [3]
Bleomycin + Thioguanine DCNZ7XA Thioguanine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Thioguanine DC9YGPN Thioguanine Renal cell carcinoma (Cell Line: SN12C) [3]
Bleomycin + 10-hydroxycamptothecin DC3KVPI 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + 10-hydroxycamptothecin DCFHTCU 10-hydroxycamptothecin Glioma (Cell Line: SF-539) [3]
Bleomycin + Topetecan DCKB9OV Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Topetecan DCEBYTT Topetecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Topetecan DC5J6R2 Topetecan Glioma (Cell Line: SF-295) [3]
Bleomycin + Topetecan DCAYJG6 Topetecan Glioma (Cell Line: SF-539) [3]
Bleomycin + Topetecan DCKA4P6 Topetecan Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Amonafide DCMTHP6 Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Amonafide DCRJQHM Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Amonafide DC3JTP7 Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Amonafide DCPQ3EJ Amonafide Astrocytoma (Cell Line: U251) [3]
Bleomycin + Amonafide DCV6R2H Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Amonafide DCJ6K17 Amonafide Glioma (Cell Line: SF-539) [3]
Bleomycin + Amonafide DCN1HIX Amonafide Glioma (Cell Line: SF-268) [3]
Bleomycin + Pralatrexate DCVL1A6 Pralatrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Pralatrexate DCF4T63 Pralatrexate Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Pralatrexate DCIPZKS Pralatrexate Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Pralatrexate DCWD1XL Pralatrexate Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Terameprocol DCVQY11 Terameprocol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Terameprocol DC4HIGA Terameprocol Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Terameprocol DCXA9D0 Terameprocol Clear cell renal cell carcinoma (Cell Line: A498) [3]
Bleomycin + Terameprocol DCTOQ9Z Terameprocol Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + SCH 727965 DCK68A0 SCH 727965 Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Ifosfamide DCXSGHJ Ifosfamide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Ifosfamide DCD5VB9 Ifosfamide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Raloxifene DC6EZM5 Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Raloxifene DCE02XZ Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Raloxifene DC19TKM Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Raloxifene DCNSE01 Raloxifene Glioma (Cell Line: SF-539) [3]
Bleomycin + Bendamustine hydrochloride DCXU6RU Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Bendamustine hydrochloride DCPP50J Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Bendamustine hydrochloride DC81S50 Bendamustine hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Bendamustine hydrochloride DCEEO2N Bendamustine hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Mitomycin DCCT645 Mitomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Mitomycin DCANU2R Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Mitomycin DCQZSLX Mitomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Mitomycin DCWYRQA Mitomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Bleomycin + Mitomycin DCAHJDN Mitomycin Glioma (Cell Line: SF-295) [3]
Bleomycin + Mitomycin DCI41LS Mitomycin Glioma (Cell Line: SF-268) [3]
Bleomycin + Mitomycin DCU1C2A Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + SY-1425 DCSPRGX SY-1425 Glioma (Cell Line: SF-539) [3]
Bleomycin + SY-1425 DCHM7B0 SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Uracil mustard DCFF1EH Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Uracil mustard DC2YRC3 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Uracil mustard DCEZYR5 Uracil mustard Astrocytoma (Cell Line: U251) [3]
Bleomycin + Uracil mustard DC9INEL Uracil mustard Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Uracil mustard DCHCP3N Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Uracil mustard DCOP4FF Uracil mustard Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Uracil mustard DC9NJFZ Uracil mustard Glioblastoma (Cell Line: SNB-75) [3]
Bleomycin + Uracil mustard DC4LYNC Uracil mustard Glioma (Cell Line: SF-539) [3]
Bleomycin + Uracil mustard DCE0ZJZ Uracil mustard Glioma (Cell Line: SF-295) [3]
Bleomycin + Uracil mustard DCENRGM Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Uracil mustard DC6AAQV Uracil mustard Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Vincristine DCESYL9 Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Vincristine DCZJG1H Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Vincristine DCDJAI6 Vincristine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Bleomycin + Vincristine DCQ26FS Vincristine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Bleomycin + Vincristine DCE1Y75 Vincristine Glioma (Cell Line: SF-295) [3]
Bleomycin + Arfolitixorin DC7YS0O Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Arfolitixorin DCAN9SJ Arfolitixorin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Arfolitixorin DCRD4G6 Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Arfolitixorin DCCLTVG Arfolitixorin Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Arfolitixorin DCG72C9 Arfolitixorin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Arfolitixorin DCE39G3 Arfolitixorin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Bleomycin + Arfolitixorin DCODVVG Arfolitixorin Glioblastoma (Cell Line: SNB-75) [3]
Bleomycin + Arfolitixorin DC1JN3F Arfolitixorin Glioma (Cell Line: SF-268) [3]
Bleomycin + Arfolitixorin DCDS4JL Arfolitixorin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Bleomycin DCJWLPN Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Bleomycin DCAXJ33 Bleomycin Astrocytoma (Cell Line: U251) [3]
Bleomycin + Bleomycin DC75KFB Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Bleomycin DCIRIXL Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Bleomycin DCWAFUK Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Bortezomib DC77QF1 Bortezomib Astrocytoma (Cell Line: U251) [3]
Bleomycin + Bortezomib DCXY3DJ Bortezomib Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Bortezomib DC45MAY Bortezomib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Bleomycin + Bortezomib DCIIBTB Bortezomib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Bleomycin + Bortezomib DCMDM00 Bortezomib Glioma (Cell Line: SF-539) [3]
Bleomycin + Bortezomib DCW8IZU Bortezomib Glioma (Cell Line: SF-295) [3]
Bleomycin + Bortezomib DC448BD Bortezomib Glioma (Cell Line: SF-268) [3]
Bleomycin + Bortezomib DC25USS Bortezomib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Dacarbazine DCXRE4P Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Dacarbazine DCFMEI7 Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Dacarbazine DCV053A Dacarbazine Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Dacarbazine DC6CNZU Dacarbazine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Dacarbazine DC0HMTN Dacarbazine Glioma (Cell Line: SF-268) [3]
Bleomycin + Dacarbazine DCBJRY2 Dacarbazine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Dacarbazine DCFJ24H Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Dacarbazine DCFXNLI Dacarbazine Renal cell carcinoma (Cell Line: SN12C) [3]
Bleomycin + Valrubicin DCMQPMV Valrubicin Astrocytoma (Cell Line: U251) [3]
Bleomycin + Valrubicin DCP50KX Valrubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Valrubicin DCQIE00 Valrubicin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Valrubicin DCFYP01 Valrubicin Glioma (Cell Line: SF-295) [3]
Bleomycin + Valrubicin DCK5S1W Valrubicin Renal cell carcinoma (Cell Line: UO-31) [3]
Bleomycin + Topotecan DCFPY92 Topotecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Topotecan DCP5X77 Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Topotecan DCOFVXM Topotecan Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Topotecan DCM19H9 Topotecan Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Topotecan DCKNJ9O Topotecan Glioblastoma (Cell Line: SNB-75) [3]
Bleomycin + Topotecan DC42A3N Topotecan Glioma (Cell Line: SF-268) [3]
Bleomycin + Topotecan DCL7SLT Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Cisplatin DCF17PK Cisplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Cisplatin DC58M1G Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Cisplatin DC91IUL Cisplatin Astrocytoma (Cell Line: U251) [3]
Bleomycin + Chlorambucil DCJ6RGM Chlorambucil Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Chlorambucil DCHYL67 Chlorambucil Astrocytoma (Cell Line: U251) [3]
Bleomycin + Chlorambucil DCYE2HW Chlorambucil Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Chlorambucil DCFOTZH Chlorambucil Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Chlorambucil DCZ97Q9 Chlorambucil Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Bleomycin + Sorafenib DC6AVJU Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Sorafenib DCGXRC9 Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Sorafenib DCU07YW Sorafenib Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Sorafenib DCEAPP9 Sorafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Sorafenib DCJGWCT Sorafenib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + ER819762 DCWGF23 ER819762 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + ER819762 DCK7A43 ER819762 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + ER819762 DCXFBWK ER819762 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + ER819762 DCQFGH5 ER819762 Renal cell carcinoma (Cell Line: SN12C) [3]
Bleomycin + Romidepsin DCYRNCL Romidepsin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Azacitidine DCQHN6W Azacitidine Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Azacitidine DCVOWR8 Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Pomalidomide DCD44FN Pomalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Pomalidomide DCJO3JA Pomalidomide Glioma (Cell Line: SF-295) [3]
Bleomycin + Vinflunine DC7BIU0 Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Vinflunine DCDMSX2 Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Vinflunine DCCODKO Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Vinflunine DCAVH70 Vinflunine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Vinflunine DC7K67Y Vinflunine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Bleomycin + Vinflunine DCRMEPZ Vinflunine Glioma (Cell Line: SF-295) [3]
Bleomycin + Vinflunine DC664XC Vinflunine Glioma (Cell Line: SF-539) [3]
Bleomycin + Mercaptopurine DCWYO7E Mercaptopurine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Mepacrine DCL8KTM Mepacrine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + FORMESTANE DCFA0AK FORMESTANE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + FORMESTANE DCBPG17 FORMESTANE Renal cell carcinoma (Cell Line: SN12C) [3]
Bleomycin + Aminolevulinic Acid Hydrochloride DC5Y2BT Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Aminolevulinic Acid Hydrochloride DCFI5K5 Aminolevulinic Acid Hydrochloride Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Bleomycin + Digitoxin DCDTT5R Digitoxin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Digitoxin DCENO7E Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Digitoxin DC6805C Digitoxin Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Digitoxin DC43BFF Digitoxin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Digitoxin DCCPUPT Digitoxin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Bleomycin + Digitoxin DC2ESS0 Digitoxin Glioma (Cell Line: SF-539) [3]
Bleomycin + Busulfan DCG8MX3 Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Busulfan DCNV7MJ Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Busulfan DCB8ZXY Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Busulfan DCF0SNB Busulfan Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Busulfan DCML76U Busulfan Glioma (Cell Line: SF-539) [3]
Bleomycin + Busulfan DCRIJ1K Busulfan Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Dasatinib DC32H6Y Dasatinib Adenocarcinoma (Cell Line: SW-620) [3]
Bleomycin + Dasatinib DCQ98JY Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Mechlorethamine DCWATN3 Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Mechlorethamine DCEFFNL Mechlorethamine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Pentostatin DC9CC3Q Pentostatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Pentostatin DCHMXYA Pentostatin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Pentostatin DCKU75S Pentostatin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Hepzato DCAHHUO Hepzato Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Dactinomycin DCSZH1K Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Dactinomycin DCPTL03 Dactinomycin Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Dactinomycin DC8GBTZ Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + PMID28460551-Compound-2 DCUXFBR PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + PMID28460551-Compound-2 DCDXQZZ PMID28460551-Compound-2 Carcinoma (Cell Line: MCF7) [4]
Bleomycin + PMID28460551-Compound-2 DC8NKNR PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + PMID28460551-Compound-2 DCDJ9YD PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + PMID28460551-Compound-2 DCJ1737 PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + LIAROZOLE DCBZMB6 LIAROZOLE Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Methotrexate DCJWQBN Methotrexate Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Isoniazid DCA962R Isoniazid Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Arsenic trioxide DC1PTL3 Arsenic trioxide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Arsenic trioxide DCPUV1O Arsenic trioxide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Plicamycin DCPEC90 Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Plicamycin DCN4DUD Plicamycin Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Plicamycin DC1Y5D5 Plicamycin Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Plicamycin DC0GGQ5 Plicamycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Plicamycin DCOCFEY Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Plicamycin DCOTLNI Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Bleomycin + Plicamycin DC2JPQA Plicamycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Thioguanine DCCADC7 Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Thioguanine DCC5QOG Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Thioguanine DCXXL8P Thioguanine Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + Thioguanine DCD6PWO Thioguanine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Topetecan DCB2H67 Topetecan Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Topetecan DCSYOMZ Topetecan Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + Topetecan DCERCPN Topetecan Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Amonafide DC1OR1P Amonafide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Amonafide DCW85OZ Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Amonafide DC4PW42 Amonafide Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + Amonafide DCGJKZD Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Terameprocol DC3HVPY Terameprocol Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Terameprocol DCXS13Y Terameprocol Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Ifosfamide DC1JAA5 Ifosfamide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Sirolimus DCP2SWU Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Mitomycin DCR6BEH Mitomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Mitomycin DCN9CI2 Mitomycin Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Mitomycin DCUU4OV Mitomycin Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Mitomycin DCPLYNB Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Mitomycin DC1GFS0 Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Bleomycin + Uracil mustard DC77FPJ Uracil mustard Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Uracil mustard DCXUUKN Uracil mustard Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Uracil mustard DC8PPA7 Uracil mustard Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Uracil mustard DC430AW Uracil mustard Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + Uracil mustard DCEE2QX Uracil mustard Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Arfolitixorin DC28901 Arfolitixorin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Arfolitixorin DCUGIYY Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Arfolitixorin DCTO0WP Arfolitixorin Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + Arfolitixorin DCCSDFP Arfolitixorin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Arfolitixorin DCYQGGX Arfolitixorin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Bleomycin DCBEIPQ Bleomycin Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Bleomycin DCFH6U5 Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Bortezomib DCMX9TW Bortezomib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Bortezomib DCCXXHB Bortezomib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Bleomycin + Bortezomib DCROSG4 Bortezomib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Dacarbazine DCVB9ZJ Dacarbazine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Dacarbazine DCZCOOE Dacarbazine Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Dacarbazine DC4ZU6Y Dacarbazine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Dacarbazine DC30TXJ Dacarbazine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Valrubicin DC72XKQ Valrubicin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Topotecan DC228VE Topotecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Topotecan DCYT0BA Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Cisplatin DC60D5U Cisplatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Chlorambucil DCO3W64 Chlorambucil Carcinoma (Cell Line: MCF7) [4]
Bleomycin + ER819762 DCCB8IP ER819762 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Romidepsin DC9NDWA Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Bleomycin + Azacitidine DCTMFIG Azacitidine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Bleomycin + Vinflunine DC9P0DT Vinflunine Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Fludarabine DCM3L9G Fludarabine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Fludarabine DCQKGH3 Fludarabine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Aminolevulinic Acid Hydrochloride DCMXZ8H Aminolevulinic Acid Hydrochloride Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Busulfan DCKJNFK Busulfan Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Dasatinib DC1ZPSX Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Dasatinib DCPOD3N Dasatinib Carcinoma (Cell Line: MCF7) [4]
Bleomycin + Mechlorethamine DC8G39I Mechlorethamine Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Bleomycin + Mechlorethamine DCINSSA Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Bleomycin + Mechlorethamine DCF7I2C Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Mechlorethamine DC788O2 Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Mechlorethamine DCO5CGN Mechlorethamine Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Mechlorethamine DC5K7A8 Mechlorethamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Mechlorethamine DC6XOP7 Mechlorethamine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Bleomycin + Pentostatin DC254CB Pentostatin Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Picoplatin DCOQR2P Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Ruxolitinib DC1WLTD Ruxolitinib Hodgkin lymphoma (Cell Line: HDLM-2) [5]
Bleomycin + Ixabepilone DCSOI37 Ixabepilone Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Ixabepilone DCINPWK Ixabepilone High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Dactinomycin DCYBE7C Dactinomycin Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Dactinomycin DCP9DDC Dactinomycin Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Dactinomycin DCQZ2UE Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Dactinomycin DCGIMQP Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Bleomycin + Dactinomycin DCEOE6X Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Bleomycin + Dactinomycin DCLVSGQ Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Dactinomycin DCA5K57 Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Dactinomycin DC43V2C Dactinomycin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Dactinomycin DCGRZJ3 Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + Dactinomycin DCSTT63 Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Dactinomycin DCSUD22 Dactinomycin Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Dactinomycin DCUTRBN Dactinomycin Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Dactinomycin DC96W2W Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Dactinomycin DCZ87XA Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Lapatinib DC72L5X Lapatinib Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Lapatinib DCQYRVM Lapatinib Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Lapatinib DCYLN1L Lapatinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Lapatinib DCV69QH Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + PMID28460551-Compound-2 DC1L2HG PMID28460551-Compound-2 Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + PMID28460551-Compound-2 DCHFSN1 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Bleomycin + PMID28460551-Compound-2 DC729RR PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + PMID28460551-Compound-2 DCDWW8I PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + PMID28460551-Compound-2 DC6ELWR PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + PMID28460551-Compound-2 DCHWSQU PMID28460551-Compound-2 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Crizotinib DCSBMJV Crizotinib Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Crizotinib DCSPDL0 Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Crizotinib DCMLJY6 Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Crizotinib DCS4G14 Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Crizotinib DCUEVX4 Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Cyclophosphamide DCTB140 Cyclophosphamide Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Cyclophosphamide DCVXTF3 Cyclophosphamide Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Panobinostat DCQUTR8 Panobinostat Hodgkin lymphoma (Cell Line: L-1236) [5]
Bleomycin + Methotrexate DCHKXIU Methotrexate Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Methotrexate DCT48IM Methotrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Bleomycin + Isoniazid DCQQ1N6 Isoniazid Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Isoniazid DCCF0HM Isoniazid Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + Arsenic trioxide DCMG8AP Arsenic trioxide Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Arsenic trioxide DCWVJNA Arsenic trioxide Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Plicamycin DC8LIP4 Plicamycin Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Plicamycin DC9G5NU Plicamycin Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Plicamycin DCOFS9Q Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + Plicamycin DCIVN4X Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Bleomycin + Plicamycin DC9DADZ Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Bleomycin + Plicamycin DC40M17 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Plicamycin DCDCHY2 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Bleomycin + Plicamycin DC4P0Z5 Plicamycin Hodgkin lymphoma (Cell Line: L-1236) [5]
Bleomycin + Plicamycin DCZHLLY Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Plicamycin DCNFVN7 Plicamycin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Plicamycin DCVHZJL Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + Plicamycin DCCLQNA Plicamycin Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Plicamycin DC70QHB Plicamycin Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Plicamycin DCSHVG5 Plicamycin Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Thioguanine DC65PZ9 Thioguanine Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Thioguanine DCOU7CJ Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Thioguanine DCY2XLW Thioguanine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Thioguanine DCU2OEZ Thioguanine Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Thioguanine DC46K49 Thioguanine Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Thioguanine DC9SK92 Thioguanine Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Thioguanine DC1UVZV Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + 10-hydroxycamptothecin DCWQPEP 10-hydroxycamptothecin Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + GDC-0084 DC26ZNV GDC-0084 Hodgkin lymphoma (Cell Line: HDLM-2) [5]
Bleomycin + GDC-0084 DCGTE8M GDC-0084 Hodgkin lymphoma (Cell Line: L-428) [5]
Bleomycin + Topetecan DC4119G Topetecan Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Topetecan DCO3LX6 Topetecan Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + Topetecan DC2TDWU Topetecan High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Topetecan DCHXMR4 Topetecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Amonafide DCGQ9G7 Amonafide Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Amonafide DC5TW0M Amonafide Adenocarcinoma (Cell Line: NCIH23) [5]
Bleomycin + Amonafide DCQK5U4 Amonafide Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Bleomycin + Amonafide DCA9RRR Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Amonafide DC5RG33 Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Amonafide DCE4RS1 Amonafide Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Amonafide DC6MSQ0 Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Amonafide DCXNKY5 Amonafide Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Pralatrexate DCPS5DI Pralatrexate Adenocarcinoma (Cell Line: NCIH23) [5]
Bleomycin + Pralatrexate DC9VMU9 Pralatrexate Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Pralatrexate DCRFQUV Pralatrexate High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Pralatrexate DCMBGLI Pralatrexate Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Pralatrexate DCFBLC0 Pralatrexate Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Pralatrexate DCTFCYE Pralatrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Terameprocol DCBZ0I3 Terameprocol Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Terameprocol DC7C367 Terameprocol Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + Terameprocol DCQJAN4 Terameprocol Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Terameprocol DCBT0E3 Terameprocol Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + Terameprocol DCPK2IF Terameprocol Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Bleomycin + Terameprocol DCTZ4HY Terameprocol Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Bleomycin + Terameprocol DCB60Z8 Terameprocol High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Terameprocol DCZ17BS Terameprocol Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Terameprocol DCS0SMZ Terameprocol Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Terameprocol DCMLMCS Terameprocol Prostate carcinoma (Cell Line: PC-3) [5]
Bleomycin + SCH 727965 DCIDS45 SCH 727965 Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + SCH 727965 DCZ15IG SCH 727965 Hodgkin lymphoma (Cell Line: L-1236) [5]
Bleomycin + Ifosfamide DC71275 Ifosfamide Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Ifosfamide DCZCGWF Ifosfamide Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Bleomycin + Bendamustine hydrochloride DCWYGNU Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Bendamustine hydrochloride DC0RFYO Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Bendamustine hydrochloride DC5VAYW Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Bendamustine hydrochloride DCQA5VI Bendamustine hydrochloride Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Bendamustine hydrochloride DCRCCB2 Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Bendamustine hydrochloride DCGHJLD Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Bendamustine hydrochloride DCO8J32 Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Mitomycin DCA5BUO Mitomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Mitomycin DC42J2M Mitomycin Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Mitomycin DCCGTPE Mitomycin Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Mitomycin DCADZIL Mitomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + SY-1425 DCCPH30 SY-1425 Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + SY-1425 DCUUD8W SY-1425 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Uracil mustard DCI0RQA Uracil mustard Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Uracil mustard DCWW4N3 Uracil mustard Adenocarcinoma (Cell Line: NCIH23) [5]
Bleomycin + Uracil mustard DCE920K Uracil mustard Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Uracil mustard DCQZMNA Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Uracil mustard DCBJW3T Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Uracil mustard DC8MU0O Uracil mustard Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Uracil mustard DC25QBO Uracil mustard Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Bleomycin + Uracil mustard DCEKZ6G Uracil mustard Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Uracil mustard DCSBNSY Uracil mustard Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Uracil mustard DCWGS9Q Uracil mustard Malignant melanoma (Cell Line: UACC62) [5]
Bleomycin + Uracil mustard DCPAVB9 Uracil mustard Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Uracil mustard DCKKDUQ Uracil mustard Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Uracil mustard DCPQ7VI Uracil mustard Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Uracil mustard DCS83AS Uracil mustard Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Uracil mustard DC8FL72 Uracil mustard Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Bleomycin + Uracil mustard DCOMKZB Uracil mustard Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Uracil mustard DCAQUUS Uracil mustard Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Vincristine DCWJMN4 Vincristine Adenocarcinoma (Cell Line: DU-145) [5]
Bleomycin + Vincristine DCR7XY0 Vincristine Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Vincristine DCWP8O3 Vincristine Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Vincristine DCQGQYQ Vincristine Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Vincristine DCCY0WI Vincristine Amelanotic melanoma (Cell Line: M14) [5]
Bleomycin + Vincristine DCO1PRX Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Vincristine DC6UVDY Vincristine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Bleomycin + Vincristine DCTBBYT Vincristine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Arfolitixorin DCNJCU6 Arfolitixorin Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Arfolitixorin DCI1SMN Arfolitixorin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Bleomycin + Arfolitixorin DC1FW9U Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Arfolitixorin DCT2Y42 Arfolitixorin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Arfolitixorin DC0UOB8 Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Arfolitixorin DC1S50O Arfolitixorin Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Arfolitixorin DCBEAE0 Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Altretamine DCVDF48 Altretamine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + AS602868 DC8K4QW AS602868 Hodgkin lymphoma (Cell Line: L-1236) [5]
Bleomycin + TEM DC107QR TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + JNK-IN-8 DCZI95D JNK-IN-8 Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + Imatinib DC9KP47 Imatinib Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + ABT-263 DCW5ILP ABT-263 Hodgkin lymphoma (Cell Line: L-1236) [5]
Bleomycin + Bleomycin DCL6CC7 Bleomycin Adenocarcinoma (Cell Line: DU-145) [5]
Bleomycin + Bleomycin DC8T3D1 Bleomycin Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Bleomycin DCJDSIV Bleomycin Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Bortezomib DCYKZ8B Bortezomib Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Bortezomib DC1VU2P Bortezomib Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Bortezomib DCCYM7P Bortezomib Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + Bortezomib DCKMGIG Bortezomib Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + Bortezomib DCDNZ4K Bortezomib Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Bortezomib DCPCBKN Bortezomib Amelanotic melanoma (Cell Line: M14) [5]
Bleomycin + Bortezomib DC3Z9MB Bortezomib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Bortezomib DCSHPSF Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Bortezomib DCJ68XO Bortezomib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Bortezomib DC3PU3I Bortezomib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Bleomycin + Bortezomib DCX3AGK Bortezomib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + Bortezomib DC9MNK6 Bortezomib Malignant melanoma (Cell Line: UACC62) [5]
Bleomycin + Bortezomib DCZFGUK Bortezomib Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Bortezomib DCOLXRJ Bortezomib Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Bortezomib DCXYPKE Bortezomib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Bortezomib DCK7YNE Bortezomib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Dacarbazine DCUD2DO Dacarbazine Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Dacarbazine DCGBORJ Dacarbazine Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Bleomycin + Dacarbazine DCQA0NB Dacarbazine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Dacarbazine DC81E7X Dacarbazine Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Dacarbazine DCHMI6O Dacarbazine Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Dacarbazine DCGJXC5 Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Dacarbazine DCKNDPY Dacarbazine Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Dacarbazine DC2V3QY Dacarbazine Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Valrubicin DCFZFSK Valrubicin Adenocarcinoma (Cell Line: NCIH23) [5]
Bleomycin + Valrubicin DCKEXHT Valrubicin Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Valrubicin DCALUK5 Valrubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Bleomycin + Valrubicin DCE872L Valrubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Bleomycin + Valrubicin DC3LASI Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Bleomycin + Valrubicin DC8296C Valrubicin Malignant melanoma (Cell Line: UACC62) [5]
Bleomycin + Valrubicin DCBOV7A Valrubicin Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Valrubicin DCR7ZOX Valrubicin Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Valrubicin DCX23MP Valrubicin Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Topotecan DCWJRFL Topotecan Adenocarcinoma (Cell Line: DU-145) [5]
Bleomycin + Topotecan DC5KX0E Topotecan Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Topotecan DCU49QO Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Topotecan DCL44KQ Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Bleomycin + Topotecan DCJWKKN Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Bleomycin + Topotecan DC9QOMI Topotecan Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Topotecan DCX29RC Topotecan Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Topotecan DCTNIQO Topotecan Melanoma (Cell Line: UACC-257) [5]
Bleomycin + Topotecan DC7LPGE Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Topotecan DCT69VW Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Topotecan DC9S15D Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Topotecan DCDAAXU Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Cisplatin DC2F94E Cisplatin Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Cisplatin DCIY604 Cisplatin Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Cisplatin DCYKN2Z Cisplatin Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Chlorambucil DCN10V5 Chlorambucil Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Chlorambucil DC7R5Y7 Chlorambucil Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + Chlorambucil DC96CWF Chlorambucil Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Bleomycin + Chlorambucil DCJZAVO Chlorambucil Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Sorafenib DCJQ6O8 Sorafenib Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Sorafenib DCGHSL4 Sorafenib Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + ER819762 DCNA72R ER819762 Adenocarcinoma (Cell Line: DU-145) [5]
Bleomycin + ER819762 DCDNAPK ER819762 Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + ER819762 DCNXP97 ER819762 Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + ER819762 DC3QSPP ER819762 Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + ER819762 DCTD2PP ER819762 Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + ER819762 DCAX3R0 ER819762 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + ER819762 DC3KHU1 ER819762 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Bleomycin + ER819762 DC9GM9Y ER819762 Prostate carcinoma (Cell Line: PC-3) [5]
Bleomycin + Romidepsin DC1ZD9I Romidepsin Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Romidepsin DCE1A9H Romidepsin Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Romidepsin DCPRQV3 Romidepsin Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Bleomycin + Romidepsin DCPTSRN Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Bleomycin + Romidepsin DCGZX52 Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Romidepsin DCIHGP8 Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + Romidepsin DCPT2H8 Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Romidepsin DC92NRY Romidepsin Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Romidepsin DCJR6ZB Romidepsin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Romidepsin DCP69O5 Romidepsin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Azacitidine DCMR0IG Azacitidine Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Azacitidine DC4FQIO Azacitidine Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Bleomycin + Azacitidine DCCV0E6 Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Azacitidine DCOGUXL Azacitidine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Azacitidine DCFZB2W Azacitidine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Pomalidomide DCJXKAW Pomalidomide Adenocarcinoma (Cell Line: HCC-2998) [5]
Bleomycin + Pomalidomide DC1MCU3 Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Bleomycin + Pomalidomide DCRJW5I Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Pomalidomide DCSVCOA Pomalidomide Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Pomalidomide DCY4TH9 Pomalidomide Malignant melanoma (Cell Line: UACC62) [5]
Bleomycin + Vinflunine DCIENGO Vinflunine Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Vinflunine DCOSJG5 Vinflunine Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Vinflunine DCGNC1G Vinflunine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Vinflunine DCPIVY4 Vinflunine Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + Mercaptopurine DCK8GEJ Mercaptopurine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Mercaptopurine DCWRKWX Mercaptopurine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Mepacrine DCV7GP8 Mepacrine Adenocarcinoma (Cell Line: HT29) [5]
Bleomycin + Mepacrine DCPP8LW Mepacrine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Fludarabine DCVDB6H Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Fludarabine DCD56WJ Fludarabine Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Fludarabine DCWSY23 Fludarabine Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + FORMESTANE DCUVHC4 FORMESTANE Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Aminolevulinic Acid Hydrochloride DCRFX81 Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: OVCAR3) [5]
Bleomycin + Aminolevulinic Acid Hydrochloride DC1GX5D Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Digitoxin DCON03K Digitoxin Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Bleomycin + Digitoxin DCP30WW Digitoxin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + BGT226 DCFIYB7 BGT226 Hodgkin lymphoma (Cell Line: L-1236) [5]
Bleomycin + Busulfan DC6MYBF Busulfan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Bleomycin + Dasatinib DCMMNFH Dasatinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Dasatinib DC92WI4 Dasatinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Cabazitaxel + Bleomycin DC2EBHQ Cabazitaxel Adenocarcinoma (Cell Line: A549) [3]
Cabazitaxel + Bleomycin DCNY6UL Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [3]
Cabazitaxel + Bleomycin DC0AXJX Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Cabazitaxel + Bleomycin DCK0ODQ Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Cabazitaxel + Bleomycin DCC69VH Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Bleomycin DC440A8 Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Bleomycin DC5ZSOA Cabazitaxel Astrocytoma (Cell Line: SNB-19) [3]
Cabazitaxel + Bleomycin DCNWSRB Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Cabazitaxel + Bleomycin DCR346H Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [3]
Cabazitaxel + Bleomycin DC80NU3 Cabazitaxel Glioblastoma (Cell Line: SNB-75) [3]
Cabazitaxel + Bleomycin DCGWP4Q Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Cabazitaxel + Bleomycin DCIG22T Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cabazitaxel + Bleomycin DCHWI12 Cabazitaxel Lung adenocarcinoma (Cell Line: HOP-62) [3]
Cabazitaxel + Bleomycin DCDVSR9 Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Cabazitaxel + Bleomycin DCXZSMZ Cabazitaxel Melanoma (Cell Line: UACC-257) [3]
Cabazitaxel + Bleomycin DCYQKZV Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Cabazitaxel + Bleomycin DCVMNBG Cabazitaxel Renal cell carcinoma (Cell Line: UO-31) [3]
Cabazitaxel + Bleomycin DC3G0K1 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [3]
Cabazitaxel + Bleomycin DCI2YV5 Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Cabazitaxel + Bleomycin DCT83ME Cabazitaxel Carcinoma (Cell Line: RXF 393) [4]
Cabazitaxel + Bleomycin DCXLQQP Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Cabazitaxel + Bleomycin DCX7OK8 Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Cabazitaxel + Bleomycin DC1H7AD Cabazitaxel Invasive ductal carcinoma (Cell Line: T-47D) [4]
Crizotinib + Bleomycin DCZRXRM Crizotinib Adenocarcinoma (Cell Line: A549) [3]
Crizotinib + Bleomycin DCDZQ3N Crizotinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Crizotinib + Bleomycin DC8WSBE Crizotinib Adenocarcinoma (Cell Line: HCT-15) [3]
Crizotinib + Bleomycin DCVVSUJ Crizotinib Adenocarcinoma (Cell Line: SW-620) [3]
Crizotinib + Bleomycin DC45ZL8 Crizotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Crizotinib + Bleomycin DCVSX93 Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Bleomycin DCBFKYY Crizotinib Astrocytoma (Cell Line: SNB-19) [3]
Crizotinib + Bleomycin DCXU7ZS Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Crizotinib + Bleomycin DCIOMT4 Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Crizotinib + Bleomycin DCGE3UK Crizotinib Glioblastoma (Cell Line: SNB-75) [3]
Crizotinib + Bleomycin DCRZPQH Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Crizotinib + Bleomycin DCJJN7B Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + Bleomycin DC7RRFS Crizotinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Crizotinib + Bleomycin DC5FAQJ Crizotinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Crizotinib + Bleomycin DCMHFVX Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Crizotinib + Bleomycin DCL03YS Crizotinib Melanoma (Cell Line: SK-MEL-2) [3]
Crizotinib + Bleomycin DC2W1U9 Crizotinib Renal cell carcinoma (Cell Line: SN12C) [3]
Crizotinib + Bleomycin DCNE0AS Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Crizotinib + Bleomycin DC81YIX Crizotinib Colon carcinoma (Cell Line: KM12) [4]
Dacarbazine + Bleomycin DC24OFM Dacarbazine Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Dacarbazine + Bleomycin DCFZ3K6 Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Bleomycin DCSAS1E Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dacarbazine + Bleomycin DCF5LZ6 Dacarbazine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Dacarbazine + Bleomycin DC78WCC Dacarbazine Melanoma (Cell Line: SK-MEL-2) [3]
Dacarbazine + Bleomycin DCFUBW8 Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Bleomycin DCOH6WD Dacarbazine Carcinoma (Cell Line: MCF7) [4]
Dacarbazine + Bleomycin DCA9FVR Dacarbazine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Bleomycin DCM6YZK Dactinomycin Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Bleomycin DC464T9 Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Bleomycin DCPT5MS Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Bleomycin DCYZBXB Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Bleomycin DCJ5RJS Dactinomycin Glioma (Cell Line: SF-295) [5]
Dactinomycin + Bleomycin DC3LMKR Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Bleomycin DCA91KJ Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Bleomycin DCHHPP0 Dactinomycin Melanoma (Cell Line: SK-MEL-2) [5]
Dactinomycin + Bleomycin DCE7305 Dactinomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dasatinib + Bleomycin DCXDGY5 Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dasatinib + Bleomycin DCUK7P2 Dasatinib Astrocytoma (Cell Line: U251) [3]
Dasatinib + Bleomycin DCA252S Dasatinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Dexrazoxane + Bleomycin DC6SQHE Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dexrazoxane + Bleomycin DC4RZEE Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dexrazoxane + Bleomycin DCXJGV9 Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dexrazoxane + Bleomycin DCUV45F Dexrazoxane Astrocytoma (Cell Line: U251) [3]
Dexrazoxane + Bleomycin DCMIRRM Dexrazoxane Astrocytoma (Cell Line: SNB-19) [3]
Dexrazoxane + Bleomycin DC49UWX Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dexrazoxane + Bleomycin DC0KI6U Dexrazoxane Chronic myelogenous leukemia (Cell Line: K-562) [3]
Dexrazoxane + Bleomycin DCQ7AOZ Dexrazoxane Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Dexrazoxane + Bleomycin DCOQCEH Dexrazoxane Glioblastoma (Cell Line: SNB-75) [3]
Dexrazoxane + Bleomycin DCC8N4R Dexrazoxane Glioma (Cell Line: SF-539) [3]
Dexrazoxane + Bleomycin DCIP6XS Dexrazoxane Glioma (Cell Line: SF-268) [3]
Dexrazoxane + Bleomycin DCFOZMF Dexrazoxane Glioma (Cell Line: SF-295) [3]
Dexrazoxane + Bleomycin DC0D80K Dexrazoxane Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dexrazoxane + Bleomycin DCWG49T Dexrazoxane Renal cell carcinoma (Cell Line: SN12C) [3]
Dexrazoxane + Bleomycin DCKLQOT Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dexrazoxane + Bleomycin DCXM80C Dexrazoxane Carcinoma (Cell Line: RXF 393) [4]
Dexrazoxane + Bleomycin DCVVOAF Dexrazoxane Carcinoma (Cell Line: MCF7) [4]
Dexrazoxane + Bleomycin DCAJEDQ Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dexrazoxane + Bleomycin DCYQULA Dexrazoxane Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dexrazoxane + Bleomycin DC1K7Y9 Dexrazoxane Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dexrazoxane + Bleomycin DCS74O3 Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dexrazoxane + Bleomycin DCXWL8B Dexrazoxane Adenocarcinoma (Cell Line: DU-145) [5]
Dexrazoxane + Bleomycin DCHKORY Dexrazoxane Adenocarcinoma (Cell Line: OVCAR3) [5]
Dexrazoxane + Bleomycin DC4T6H2 Dexrazoxane Adenocarcinoma (Cell Line: HCC-2998) [5]
Dexrazoxane + Bleomycin DCXC9B2 Dexrazoxane Adenocarcinoma (Cell Line: SW-620) [5]
Dexrazoxane + Bleomycin DC5C9SU Dexrazoxane Adenocarcinoma (Cell Line: HCT-15) [5]
Dexrazoxane + Bleomycin DC4ZGI8 Dexrazoxane Amelanotic melanoma (Cell Line: M14) [5]
Dexrazoxane + Bleomycin DC2QFTK Dexrazoxane Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dexrazoxane + Bleomycin DC8ZDTK Dexrazoxane Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dexrazoxane + Bleomycin DCDA8MV Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dexrazoxane + Bleomycin DC7VZKC Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dexrazoxane + Bleomycin DC1QT8A Dexrazoxane Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dexrazoxane + Bleomycin DC7U4JQ Dexrazoxane Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dexrazoxane + Bleomycin DC75FA9 Dexrazoxane Malignant melanoma (Cell Line: UACC62) [5]
Dexrazoxane + Bleomycin DC4PIVY Dexrazoxane Malignant melanoma (Cell Line: LOX IMVI) [5]
Dexrazoxane + Bleomycin DCBEI0C Dexrazoxane Melanoma (Cell Line: SK-MEL-2) [5]
Dexrazoxane + Bleomycin DCUD8M4 Dexrazoxane Melanoma (Cell Line: UACC-257) [5]
Dexrazoxane + Bleomycin DC0JXLD Dexrazoxane Melanoma (Cell Line: MALME-3M) [5]
Dexrazoxane + Bleomycin DC9QT4W Dexrazoxane Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dexrazoxane + Bleomycin DCXXT5N Dexrazoxane Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Dexrazoxane + Bleomycin DCDOJCP Dexrazoxane Prostate carcinoma (Cell Line: PC-3) [5]
Digitoxin + Bleomycin DCY0XD6 Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Digitoxin + Bleomycin DCD2RNH Digitoxin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Digitoxin + Bleomycin DCBOT5L Digitoxin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Digitoxin + Bleomycin DC0EN6J Digitoxin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Docetaxel + Bleomycin DCD06SR Docetaxel Adenocarcinoma (Cell Line: DU-145) [3]
Docetaxel + Bleomycin DCXL5BZ Docetaxel Amelanotic melanoma (Cell Line: M14) [3]
Docetaxel + Bleomycin DC3PLSF Docetaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Docetaxel + Bleomycin DCWH0L5 Docetaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Docetaxel + Bleomycin DCGGES7 Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Docetaxel + Bleomycin DC3YW31 Docetaxel Glioma (Cell Line: SF-295) [3]
Docetaxel + Bleomycin DCC3B3P Docetaxel Lung adenocarcinoma (Cell Line: EKVX) [3]
Docetaxel + Bleomycin DC2UNN7 Docetaxel Malignant melanoma (Cell Line: LOX IMVI) [3]
Docetaxel + Bleomycin DCPUWUR Docetaxel Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Docetaxel + Bleomycin DCTA56S Docetaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Epirubicin + Bleomycin DCXR7T1 Epirubicin Astrocytoma (Cell Line: SNB-19) [3]
Epirubicin + Bleomycin DCC5DAG Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Epirubicin + Bleomycin DCTQS27 Epirubicin Glioma (Cell Line: SF-539) [3]
Epirubicin + Bleomycin DCHVUCA Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Epirubicin + Bleomycin DC02C0S Epirubicin Renal cell carcinoma (Cell Line: UO-31) [3]
Epirubicin + Bleomycin DCX0AH2 Epirubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Epirubicin + Bleomycin DCQYJR1 Epirubicin Carcinoma (Cell Line: RXF 393) [4]
Epirubicin + Bleomycin DCLSNJB Epirubicin Colon carcinoma (Cell Line: KM12) [4]
Epirubicin + Bleomycin DCXCF0W Epirubicin Adenocarcinoma (Cell Line: A549) [5]
Epirubicin + Bleomycin DCH32OK Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Epirubicin + Bleomycin DCEPBXU Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Epirubicin + Bleomycin DCNSYU1 Epirubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Fludarabine + Bleomycin DCXJZAJ Fludarabine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Fludarabine + Bleomycin DCL11TU Fludarabine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Gefitinib + Bleomycin DCY1E51 Gefitinib Adenocarcinoma (Cell Line: DU-145) [3]
Gefitinib + Bleomycin DCWI2LB Gefitinib Adenocarcinoma (Cell Line: A549) [3]
Gefitinib + Bleomycin DC6W7EY Gefitinib Adenocarcinoma (Cell Line: NCIH23) [3]
Gefitinib + Bleomycin DCBSMIW Gefitinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Gefitinib + Bleomycin DCU8Q6E Gefitinib Adenocarcinoma (Cell Line: HCT116) [3]
Gefitinib + Bleomycin DCGAO0P Gefitinib Adenocarcinoma (Cell Line: SW-620) [3]
Gefitinib + Bleomycin DCTQXPG Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Gefitinib + Bleomycin DCWHCNF Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Gefitinib + Bleomycin DCV6PJO Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + Bleomycin DCGLNOF Gefitinib Astrocytoma (Cell Line: U251) [3]
Gefitinib + Bleomycin DCNSAZL Gefitinib Astrocytoma (Cell Line: SNB-19) [3]
Gefitinib + Bleomycin DCOZFXQ Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Gefitinib + Bleomycin DC9TS89 Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Gefitinib + Bleomycin DC8V7MP Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Gefitinib + Bleomycin DC8XBS0 Gefitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Gefitinib + Bleomycin DCRXOWO Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Gefitinib + Bleomycin DCQXVDQ Gefitinib Glioma (Cell Line: SF-268) [3]
Gefitinib + Bleomycin DC8C33C Gefitinib Glioma (Cell Line: SF-295) [3]
Gefitinib + Bleomycin DCIKIO7 Gefitinib Glioma (Cell Line: SF-539) [3]
Gefitinib + Bleomycin DCIRMB9 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Gefitinib + Bleomycin DCOZPVF Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Gefitinib + Bleomycin DC1PN9Q Gefitinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Gefitinib + Bleomycin DCLQVQJ Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Gefitinib + Bleomycin DCUCWZB Gefitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Gefitinib + Bleomycin DCKUVDE Gefitinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Gefitinib + Bleomycin DCTT71U Gefitinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Gefitinib + Bleomycin DCLTHYZ Gefitinib Melanoma (Cell Line: SK-MEL-2) [3]
Gefitinib + Bleomycin DC0UU7L Gefitinib Melanoma (Cell Line: UACC-257) [3]
Gefitinib + Bleomycin DCSOTIW Gefitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Gefitinib + Bleomycin DC7J4C3 Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Bleomycin DCULSIG Gefitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Gefitinib + Bleomycin DCSQXY3 Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Gefitinib + Bleomycin DCY227G Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Gefitinib + Bleomycin DC4AT0C Gefitinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Gefitinib + Bleomycin DC4I7JE Gefitinib Renal cell carcinoma (Cell Line: UO-31) [3]
Gefitinib + Bleomycin DCJSKY7 Gefitinib Renal cell carcinoma (Cell Line: SN12C) [3]
Gefitinib + Bleomycin DCWUWTC Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Gefitinib + Bleomycin DCJ3Y7H Gefitinib Colon carcinoma (Cell Line: KM12) [4]
Gefitinib + Bleomycin DCZ2ZDC Gefitinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Gefitinib + Bleomycin DCRU2CF Gefitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Hepzato + Bleomycin DCLQAEF Hepzato Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Indazole derivative 5 + Bleomycin DC7I8ZO Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Bleomycin DCWN7L4 Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [3]
Indazole derivative 5 + Bleomycin DC79SRO Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Indazole derivative 5 + Bleomycin DC3H0SY Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Indazole derivative 5 + Bleomycin DCIL6Y3 Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Indazole derivative 5 + Bleomycin DCAFGKS Indazole derivative 5 Glioblastoma (Cell Line: SNB-75) [3]
Indazole derivative 5 + Bleomycin DCQYM71 Indazole derivative 5 Renal cell carcinoma (Cell Line: SN12C) [3]
Indazole derivative 5 + Bleomycin DCVZL2H Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Indazole derivative 5 + Bleomycin DCP663P Indazole derivative 5 Adenocarcinoma (Cell Line: SW-620) [5]
Indazole derivative 5 + Bleomycin DC67VHN Indazole derivative 5 Adenocarcinoma (Cell Line: HCT-15) [5]
Indazole derivative 5 + Bleomycin DCNQORV Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Indazole derivative 5 + Bleomycin DCLJLFK Indazole derivative 5 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Indazole derivative 5 + Bleomycin DC9KK61 Indazole derivative 5 Lung adenocarcinoma (Cell Line: EKVX) [5]
Indazole derivative 5 + Bleomycin DCZ63K7 Indazole derivative 5 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Indazole derivative 5 + Bleomycin DCDXJN8 Indazole derivative 5 Malignant melanoma (Cell Line: LOX IMVI) [5]
Indazole derivative 5 + Bleomycin DCVERL9 Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
JNK-IN-8 + Bleomycin DCUVY2I JNK-IN-8 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
JNK-IN-8 + Bleomycin DCFM8G7 JNK-IN-8 Chronic myelogenous leukemia (Cell Line: K-562) [3]
JNK-IN-8 + Bleomycin DCW706A JNK-IN-8 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
JNK-IN-8 + Bleomycin DCC83AV JNK-IN-8 Carcinoma (Cell Line: MCF7) [4]
JNK-IN-8 + Bleomycin DCKB2BN JNK-IN-8 Melanoma (Cell Line: SK-MEL-2) [5]
Lenalidomide + Bleomycin DC3RI4F Lenalidomide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Lenalidomide + Bleomycin DCGPT8C Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Lenalidomide + Bleomycin DCOQUAM Lenalidomide Glioma (Cell Line: SF-539) [3]
Lenalidomide + Bleomycin DCVPC0X Lenalidomide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Lenalidomide + Bleomycin DCD7EFC Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Lenalidomide + Bleomycin DCJFJT0 Lenalidomide Adenocarcinoma (Cell Line: A549) [5]
Lenalidomide + Bleomycin DCFJ3CQ Lenalidomide Adenocarcinoma (Cell Line: SW-620) [5]
Lenalidomide + Bleomycin DC994HE Lenalidomide Adenocarcinoma (Cell Line: HCC-2998) [5]
Lenalidomide + Bleomycin DCOU0NF Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Lenalidomide + Bleomycin DCDA98Z Lenalidomide Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Lenalidomide + Bleomycin DCCFM9N Lenalidomide Lung adenocarcinoma (Cell Line: EKVX) [5]
Lenalidomide + Bleomycin DCMD504 Lenalidomide Malignant melanoma (Cell Line: LOX IMVI) [5]
Lenalidomide + Bleomycin DCNVKN8 Lenalidomide Melanoma (Cell Line: UACC-257) [5]
Lenalidomide + Bleomycin DC7RMS7 Lenalidomide Melanoma (Cell Line: SK-MEL-2) [5]
Lenalidomide + Bleomycin DCFWV0U Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Letrozole + Bleomycin DCN2ZVM Letrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
LIAROZOLE + Bleomycin DCQWJ9L LIAROZOLE Chronic myelogenous leukemia (Cell Line: K-562) [3]
LIAROZOLE + Bleomycin DCN915V LIAROZOLE Adenocarcinoma (Cell Line: HCT116) [5]
Mechlorethamine + Bleomycin DCFSNFN Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mechlorethamine + Bleomycin DC51QY3 Mechlorethamine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Mechlorethamine + Bleomycin DC4COPS Mechlorethamine Adenocarcinoma (Cell Line: HT29) [5]
Mechlorethamine + Bleomycin DCISD7X Mechlorethamine Melanoma (Cell Line: SK-MEL-2) [5]
Nilotinib + Bleomycin DCQ0TG9 Nilotinib Adenocarcinoma (Cell Line: HT29) [5]
Nilotinib + Bleomycin DCBJR6F Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Picoplatin + Bleomycin DC92JF2 Picoplatin Carcinoma (Cell Line: MCF7) [4]
Picoplatin + Bleomycin DCIJ03W Picoplatin Melanoma (Cell Line: SK-MEL-2) [5]
Plicamycin + Bleomycin DCT6KQL Plicamycin Glioma (Cell Line: SF-295) [3]
Plicamycin + Bleomycin DCEXPQS Plicamycin Glioma (Cell Line: SF-539) [3]
Plicamycin + Bleomycin DCRA84O Plicamycin Adenocarcinoma (Cell Line: A549) [5]
Plicamycin + Bleomycin DCD4IIN Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [5]
Plicamycin + Bleomycin DC9765K Plicamycin Adenocarcinoma (Cell Line: HT29) [5]
Plicamycin + Bleomycin DCHK17X Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Plicamycin + Bleomycin DCFLHKX Plicamycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
PMID28460551-Compound-2 + Bleomycin DCR7W8B PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
PMID28460551-Compound-2 + Bleomycin DCZ0S4C PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [3]
PMID28460551-Compound-2 + Bleomycin DC5XC11 PMID28460551-Compound-2 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
PMID28460551-Compound-2 + Bleomycin DCBQ3P9 PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
PMID28460551-Compound-2 + Bleomycin DCXTWRV PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH23) [5]
PMID28460551-Compound-2 + Bleomycin DCEDVB1 PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
PMID28460551-Compound-2 + Bleomycin DC3XF02 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Raloxifene + Bleomycin DCRJCUI Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Raloxifene + Bleomycin DCR6AF5 Raloxifene Glioma (Cell Line: SF-295) [3]
Raloxifene + Bleomycin DCWPU5U Raloxifene Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Raloxifene + Bleomycin DCWUYXI Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Raloxifene + Bleomycin DCEXMNM Raloxifene Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Romidepsin + Bleomycin DC8THSJ Romidepsin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Romidepsin + Bleomycin DCEUD0F Romidepsin Astrocytoma (Cell Line: U251) [3]
Romidepsin + Bleomycin DC4RFKU Romidepsin Glioma (Cell Line: SF-539) [3]
Romidepsin + Bleomycin DCWSEWS Romidepsin Glioma (Cell Line: SF-295) [3]
Romidepsin + Bleomycin DCWJ3I8 Romidepsin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Romidepsin + Bleomycin DC2IDPV Romidepsin Carcinoma (Cell Line: RXF 393) [4]
Romidepsin + Bleomycin DCS6XWQ Romidepsin Adenocarcinoma (Cell Line: NCIH23) [5]
Romidepsin + Bleomycin DCZ5TZD Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Romidepsin + Bleomycin DCVYN8O Romidepsin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Romidepsin + Bleomycin DCCR2TV Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Romidepsin + Bleomycin DCRPTR6 Romidepsin Melanoma (Cell Line: SK-MEL-2) [5]
Ruxolitinib + Bleomycin DCT49AZ Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Ruxolitinib + Bleomycin DC17J7T Ruxolitinib Astrocytoma (Cell Line: SNB-19) [3]
Ruxolitinib + Bleomycin DCMEO4P Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Ruxolitinib + Bleomycin DCZ5XTU Ruxolitinib Renal cell carcinoma (Cell Line: SN12C) [3]
Ruxolitinib + Bleomycin DC95FTC Ruxolitinib Carcinoma (Cell Line: MCF7) [4]
Ruxolitinib + Bleomycin DCVND6T Ruxolitinib Colon carcinoma (Cell Line: KM12) [4]
Ruxolitinib + Bleomycin DCF5AJ0 Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [5]
Ruxolitinib + Bleomycin DCP0ZND Ruxolitinib Adenocarcinoma (Cell Line: A549) [5]
Ruxolitinib + Bleomycin DCK63BX Ruxolitinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Ruxolitinib + Bleomycin DCF8CKM Ruxolitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Ruxolitinib + Bleomycin DC8KX8J Ruxolitinib Malignant melanoma (Cell Line: LOX IMVI) [5]
SCH 727965 + Bleomycin DCPVDEH SCH 727965 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Sirolimus + Bleomycin DCFFN30 Sirolimus Anaplastic large cell lymphoma (Cell Line: SR) [3]
Sirolimus + Bleomycin DCAMOY2 Sirolimus Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Sirolimus + Bleomycin DCBFVD1 Sirolimus Melanoma (Cell Line: UACC-257) [5]
SY-1425 + Bleomycin DCJ8WMW SY-1425 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Taxol + Bleomycin DCBJG0Z Taxol Astrocytoma (Cell Line: U251) [3]
Taxol + Bleomycin DCJ1UTX Taxol Astrocytoma (Cell Line: SNB-19) [3]
Taxol + Bleomycin DCBGIS3 Taxol Glioma (Cell Line: SF-539) [3]
Taxol + Bleomycin DC7Q0GR Taxol Invasive ductal carcinoma (Cell Line: T-47D) [4]
Taxol + Bleomycin DCC1FD2 Taxol Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Taxol + Bleomycin DCELB7G Taxol Lung adenocarcinoma (Cell Line: EKVX) [5]
TEM + Bleomycin DCNSHD7 TEM Plasma cell myeloma (Cell Line: RPMI-8226) [3]
TEM + Bleomycin DC7RYQN TEM Lung adenocarcinoma (Cell Line: EKVX) [5]
TEM + Bleomycin DCH9OR1 TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Thioguanine + Bleomycin DCB1S7W Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Thioguanine + Bleomycin DCUCX77 Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Thioguanine + Bleomycin DCVG1Y0 Thioguanine Astrocytoma (Cell Line: U251) [3]
Thioguanine + Bleomycin DCWXLZZ Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Thioguanine + Bleomycin DCO497D Thioguanine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Thioguanine + Bleomycin DCT7QZS Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Thioguanine + Bleomycin DCTNR2E Thioguanine Glioblastoma (Cell Line: SNB-75) [3]
Thioguanine + Bleomycin DCXA8OV Thioguanine Glioma (Cell Line: SF-268) [3]
Thioguanine + Bleomycin DCNU84W Thioguanine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Thioguanine + Bleomycin DCP66T0 Thioguanine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Thioguanine + Bleomycin DCUF4Q1 Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Thioguanine + Bleomycin DCHY3XY Thioguanine Carcinoma (Cell Line: MCF7) [4]
Thioguanine + Bleomycin DCULA3B Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Thioguanine + Bleomycin DC7UKFJ Thioguanine Adenocarcinoma (Cell Line: DU-145) [5]
Thioguanine + Bleomycin DCDFWO9 Thioguanine Adenocarcinoma (Cell Line: OVCAR3) [5]
Thioguanine + Bleomycin DCSBA0G Thioguanine Adenocarcinoma (Cell Line: HCC-2998) [5]
Thioguanine + Bleomycin DC1QN5C Thioguanine Adenocarcinoma (Cell Line: SW-620) [5]
Thioguanine + Bleomycin DC2ZSQ2 Thioguanine Adenocarcinoma (Cell Line: HT29) [5]
Thioguanine + Bleomycin DCK8G02 Thioguanine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Thioguanine + Bleomycin DCRGTTJ Thioguanine Melanoma (Cell Line: MALME-3M) [5]
Thioguanine + Bleomycin DCUAXJL Thioguanine Melanoma (Cell Line: UACC-257) [5]
Thioguanine + Bleomycin DCG67TU Thioguanine Melanoma (Cell Line: SK-MEL-2) [5]
Thioguanine + Bleomycin DCD7ES7 Thioguanine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Topotecan + Bleomycin DCAL5YJ Topotecan Adenocarcinoma (Cell Line: A549) [5]
Topotecan + Bleomycin DCC279J Topotecan Adenocarcinoma (Cell Line: HT29) [5]
Topotecan + Bleomycin DCJPGGH Topotecan Adenocarcinoma (Cell Line: HCC-2998) [5]
Topotecan + Bleomycin DCTGTJQ Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Topotecan + Bleomycin DCU3EH0 Topotecan Chronic myelogenous leukemia (Cell Line: K-562) [5]
Topotecan + Bleomycin DCPC055 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Topotecan + Bleomycin DCN13MU Topotecan Melanoma (Cell Line: SK-MEL-2) [5]
Topotecan + Bleomycin DC9PVJH Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Topotecan + Bleomycin DC333OW Topotecan Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Trifluridine + Bleomycin DC4YQ6A Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Bleomycin DCN0IS6 Trifluridine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Bleomycin DCY29QR Trifluridine Astrocytoma (Cell Line: U251) [3]
Trifluridine + Bleomycin DCJ7TKD Trifluridine Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Bleomycin DCCO7R5 Trifluridine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Trifluridine + Bleomycin DCTA1ML Trifluridine Glioma (Cell Line: SF-539) [3]
Trifluridine + Bleomycin DC74FDF Trifluridine Glioma (Cell Line: SF-268) [3]
Trifluridine + Bleomycin DC3EYMP Trifluridine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Trifluridine + Bleomycin DCI1SOY Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Bleomycin DCTCRIR Trifluridine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Bleomycin DCNYE51 Trifluridine Colon carcinoma (Cell Line: KM12) [4]
Trifluridine + Bleomycin DCUF5SM Trifluridine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Bleomycin DC36LMH Trifluridine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Bleomycin DCGRARS Trifluridine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Bleomycin DCHIW65 Trifluridine Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Bleomycin DCAKXNZ Trifluridine Adenocarcinoma (Cell Line: HT29) [5]
Trifluridine + Bleomycin DCVR5FD Trifluridine Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Bleomycin DCOJW22 Trifluridine Lung adenocarcinoma (Cell Line: HOP-62) [5]
Trifluridine + Bleomycin DCPS8H3 Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Bleomycin DCQV08B Trifluridine Melanoma (Cell Line: UACC-257) [5]
Trifluridine + Bleomycin DCZ8SM2 Trifluridine Melanoma (Cell Line: SK-MEL-2) [5]
Trifluridine + Bleomycin DC4ZWJU Trifluridine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Uracil mustard + Bleomycin DCH6FYD Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Bleomycin DC914BL Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Bleomycin DC558DV Uracil mustard Glioma (Cell Line: SF-268) [3]
Uracil mustard + Bleomycin DCWS3JF Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Bleomycin DCQHQN1 Uracil mustard Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Bleomycin DC3C860 Uracil mustard Adenocarcinoma (Cell Line: HCT-15) [5]
Uracil mustard + Bleomycin DCZ872N Uracil mustard Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Bleomycin DC1T8BQ Uracil mustard Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vandetanib + Bleomycin DC542BR Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + Bleomycin DCJO42M Vandetanib Colon carcinoma (Cell Line: KM12) [4]
Vandetanib + Bleomycin DCPLPMI Vandetanib Adenocarcinoma (Cell Line: A549) [5]
Vandetanib + Bleomycin DCEAIMB Vandetanib Adenocarcinoma (Cell Line: HT29) [5]
Vandetanib + Bleomycin DC0NDF7 Vandetanib Adenocarcinoma (Cell Line: SW-620) [5]
Vandetanib + Bleomycin DCKFYR9 Vandetanib Adenocarcinoma (Cell Line: HCT-15) [5]
Vandetanib + Bleomycin DCPU1BF Vandetanib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vandetanib + Bleomycin DC1HJYQ Vandetanib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Vandetanib + Bleomycin DCDXD6A Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vandetanib + Bleomycin DCZ85NY Vandetanib Astrocytoma (Cell Line: SNB-19) [5]
Vandetanib + Bleomycin DCWDW4D Vandetanib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Vandetanib + Bleomycin DCLS3QE Vandetanib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vandetanib + Bleomycin DCJNWMV Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vandetanib + Bleomycin DCRC964 Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vandetanib + Bleomycin DCQK4N1 Vandetanib Glioma (Cell Line: SF-539) [5]
Vandetanib + Bleomycin DCV45FC Vandetanib Glioma (Cell Line: SF-295) [5]
Vandetanib + Bleomycin DCTGAJQ Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vandetanib + Bleomycin DCINPM3 Vandetanib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vandetanib + Bleomycin DCLUJ8N Vandetanib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vandetanib + Bleomycin DCB9YS4 Vandetanib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vandetanib + Bleomycin DCRSRV7 Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vandetanib + Bleomycin DCQTCJ3 Vandetanib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vandetanib + Bleomycin DCREE1I Vandetanib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vandetanib + Bleomycin DCPJUIG Vandetanib Renal cell carcinoma (Cell Line: SN12C) [5]
Vemurafenib + Bleomycin DCM93CZ Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vemurafenib + Bleomycin DCH06OI Vemurafenib Colon carcinoma (Cell Line: KM12) [4]
Vemurafenib + Bleomycin DCJ4F9G Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vemurafenib + Bleomycin DCXJYOJ Vemurafenib Adenocarcinoma (Cell Line: HT29) [5]
Vemurafenib + Bleomycin DCTX8I9 Vemurafenib Astrocytoma (Cell Line: SNB-19) [5]
Vemurafenib + Bleomycin DCG9FEZ Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vemurafenib + Bleomycin DCJCMNN Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vemurafenib + Bleomycin DCB9TIJ Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vemurafenib + Bleomycin DCFXYDM Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vemurafenib + Bleomycin DCGJXCB Vemurafenib Glioblastoma (Cell Line: SNB-75) [5]
Vemurafenib + Bleomycin DCLZWWP Vemurafenib Glioma (Cell Line: SF-539) [5]
Vemurafenib + Bleomycin DCGVNST Vemurafenib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vemurafenib + Bleomycin DCXPCF2 Vemurafenib Malignant melanoma (Cell Line: UACC62) [5]
Vemurafenib + Bleomycin DCA6P5H Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vemurafenib + Bleomycin DCBKHWY Vemurafenib Melanoma (Cell Line: UACC-257) [5]
Vincristine + Bleomycin DCX1278 Vincristine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Vincristine + Bleomycin DC3N3C9 Vincristine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Vincristine + Bleomycin DCKWMCP Vincristine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Vismodegib + Bleomycin DCQ775X Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vismodegib + Bleomycin DCVQM7S Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Bleomycin DC0WJ4C Vismodegib Adenocarcinoma (Cell Line: A549) [5]
Vismodegib + Bleomycin DC7K6Q7 Vismodegib Adenocarcinoma (Cell Line: HCT-15) [5]
Vismodegib + Bleomycin DC8MVJI Vismodegib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vismodegib + Bleomycin DC00AQK Vismodegib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Vismodegib + Bleomycin DC4NY77 Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vismodegib + Bleomycin DCHSPRT Vismodegib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vismodegib + Bleomycin DCEH0DB Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vismodegib + Bleomycin DCSFDPF Vismodegib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vismodegib + Bleomycin DC1JOBK Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vismodegib + Bleomycin DCXJ1ZS Vismodegib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vismodegib + Bleomycin DC5C3R6 Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vismodegib + Bleomycin DCTLBAW Vismodegib Malignant melanoma (Cell Line: UACC62) [5]
Vismodegib + Bleomycin DC36EKL Vismodegib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vismodegib + Bleomycin DCN8IB2 Vismodegib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vismodegib + Bleomycin DC8336B Vismodegib Renal cell carcinoma (Cell Line: UO-31) [5]
Vismodegib + Bleomycin DCHGLVO Vismodegib Renal cell carcinoma (Cell Line: SN12C) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1076 DrugCom(s)

References

1 Bleomycin FDA Label
2 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.